1. Home
  2. NBIX vs FUTU Comparison

NBIX vs FUTU Comparison

Compare NBIX & FUTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$162.00

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Logo Futu Holdings Limited

FUTU

Futu Holdings Limited

HOLD

Current Price

$110.37

Market Cap

14.7B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBIX
FUTU
Founded
1992
2011
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
14.7B
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
NBIX
FUTU
Price
$162.00
$110.37
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
22
4
Target Price
$180.91
$217.75
AVG Volume (30 Days)
1.3M
1.3M
Earning Date
05-05-2026
05-28-2026
Dividend Yield
N/A
3.39%
EPS Growth
41.95
N/A
EPS
3.30
N/A
Revenue
$161,626,000.00
N/A
Revenue This Year
$24.73
$27.96
Revenue Next Year
$13.14
$11.89
P/E Ratio
$50.32
$17.05
Revenue Growth
977.51
N/A
52 Week Low
$122.14
$80.50
52 Week High
$186.12
$202.53

Technical Indicators

Market Signals
Indicator
NBIX
FUTU
Relative Strength Index (RSI) 40.24 62.57
Support Level $153.96 $91.06
Resistance Level $169.57 $155.54
Average True Range (ATR) 6.37 3.66
MACD -2.08 1.39
Stochastic Oscillator 0.64 93.34

Price Performance

Historical Comparison
NBIX
FUTU

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

About FUTU Futu Holdings Limited

Futu Holdings Ltd is an online broker providing one-stop online investing services.. Through its proprietary digital platforms, Futubull and Moomoo, the Company provides a full range of investment services, including trade execution and clearing, margin financing and securities lending, and wealth management. The Group engages in online brokerage services and margin financing services. It generates its revenue in the form of brokerage commission and handling charge services, and interest income. Geographically, it operates in Hong Kong, which derives key revenue and it also has its presence in other countries.

Share on Social Networks: